InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
10
T+90 hit rate
58%
T+90 mean return
+11.5%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Mutz Christopher, Responsable. Officer active across 1 company, notably ANI Pharmaceuticals INC. Aggregated, 30 filings have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €2.7m. History available since 15 February 2022. The latest transaction was filed on 6 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations30 total
3,602 shares@ US$74.180.013% mcap5.7% of flowCommon StockSEC:0001846487-26-000012:2
3,314 shares@ US$74.040.012% mcap5.2% of flowCommon StockSEC:0001846487-26-000012:1
2,121 shares@ US$74.220.0076% mcap3.3% of flowCommon StockSEC:0001846487-26-000012:0
5,323 shares@ US$78.020.020% mcap47.2% of flowCommon StockSEC:0001846487-26-000006:0
5,323 shares@ US$78.0247.2% of flowCommon StockSEC:0001846487-26-000006
3,173 shares@ US$76.705.1% of flowCommon StockSEC:0001846487-26-000004:0
7,032 shares@ US$76.5511.2% of flowCommon StockSEC:0001846487-26-000004:1
2,403 shares@ US$77.363.9% of flowCommon StockSEC:0001846487-26-000004:2
4,000 shares@ US$60.455.3% of flowCommon StockSEC:0001846487-25-000008:0
2,874 shares@ US$60.624.0% of flowCommon StockSEC:0001846487-25-000006:0
1,275 shares@ US$61.891.9% of flowCommon StockSEC:0001846487-25-000004:0
24,808 shares0Common StockSEC:0001846487-25-000002:0
16,538 shares0Common StockSEC:0001846487-25-000002:1
1,473 shares@ US$58.922.0% of flowCommon StockSEC:0001846487-25-000002:2
1,184 shares@ US$58.921.6% of flowCommon StockSEC:0001846487-25-000002:3
6,500 shares@ US$57.708.8% of flowCommon StockSEC:0001846487-24-000014:0
2,000 shares@ US$61.612.8% of flowCommon StockSEC:0001846487-24-000012:0
2,110 shares@ US$66.713.2% of flowCommon StockSEC:0001846487-24-000010:0
5,000 shares@ US$66.007.5% of flowCommon StockSEC:0001846487-24-000008:0
1,275 shares@ US$67.672.0% of flowCommon StockSEC:0001846487-24-000006:0
1,261 shares@ US$57.551.7% of flowCommon StockSEC:0001846487-24-000004:0
18,790 shares0Common StockSEC:0001846487-24-000002:0
3,000 shares@ US$52.473.6% of flowCommon StockSEC:0001846487-23-000003:0
17,369 shares0Common StockSEC:0001104659-23-041738:0
11,578 shares0Common StockSEC:0001104659-23-041738:1
25 of 30 declarations
About Mutz Christopher
Christopher Mutz is the Head of Rare Disease at ANI PHARMACEUTICALS INC. His role is to lead initiatives related to rare diseases, focusing on innovation and treatment development. His expertise is essential for the success of the organization.
